close
close

(Society)Food and Drug Administration approves emergency use of COVID-19 vaccine for infants

(Society)Food and Drug Administration approves emergency use of COVID-19 vaccine for infants

A vaccine for infants and young children, intended to respond to the COVID-19 variant, has been urgently approved.

The Ministry of Food and Drug Safety announced today (21) that it has approved the COVID-19 mutation vaccine JN.1 for emergency use in infants and toddlers from 6 months to 4 years.

Emergency Use Authorization is a system that allows the Ministry of Food and Drug Safety to manufacture or import unauthorized products at the request of the head of the relevant agency to respond to a public health crisis .

Previously, the Korea Centers for Disease Control and Prevention requested emergency use authorization from the Ministry of Food and Drug Safety for the inoculation of infants and toddlers.

※ “Your report becomes news”
(Kakao Talk) Search YTN and add channel
(Phone) 02-398-8585
(Mail) [email protected]

(Copyright Holder (c) YTN Unauthorized reproduction, redistribution and use of AI data prohibited)